Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope.
Saved in:
| Title: | Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope. |
|---|---|
| Authors: | Baumgaertner P; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland., Costa Nunes C; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland., Cachot A; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland., Maby-El Hajjami H; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne, Switzerland; Department of Oncology, University Hospital Center (CHUV), Lausanne, Switzerland., Cagnon L; Department of Oncology, University Hospital Center (CHUV) , Lausanne, Switzerland., Braun M; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland., Derré L; Urology Research Unit, Urology Department, University Hospital Center (CHUV) , Lausanne, Switzerland., Rivals JP; Department of Otorhinolaryngology - Head and Neck Surgery, CHUV, University of Lausanne , Switzerland., Rimoldi D; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland., Gnjatic S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , New York, USA., Abed Maillard S; Department of Oncology, University Hospital Center (CHUV) , Lausanne, Switzerland., Marcos Mondéjar P; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne, Switzerland; Department of Oncology, University Hospital Center (CHUV), Lausanne, Switzerland., Protti MP; Tumor Immunology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Romano E; Department of Oncology, University Hospital Center (CHUV) , Lausanne, Switzerland., Michielin O; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne, Switzerland; Department of Oncology, University Hospital Center (CHUV), Lausanne, Switzerland., Romero P; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne, Switzerland; Department of Oncology, University Hospital Center (CHUV), Lausanne, Switzerland., Speiser DE; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne, Switzerland; Department of Oncology, University Hospital Center (CHUV), Lausanne, Switzerland., Jandus C; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland. |
| Source: | Oncoimmunology [Oncoimmunology] 2016 Sep 09; Vol. 5 (10), pp. e1216290. Date of Electronic Publication: 2016 Sep 09 (Print Publication: 2016). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27853637 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8<superscript>+</superscript> and CD4<superscript>+</superscript> T-cell responses with multiple specificities including a novel DR7-restricted epitope. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Baumgaertner+P%22">Baumgaertner P</searchLink>; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland.<br /><searchLink fieldCode="AU" term="%22Costa+Nunes+C%22">Costa Nunes C</searchLink>; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland.<br /><searchLink fieldCode="AU" term="%22Cachot+A%22">Cachot A</searchLink>; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland.<br /><searchLink fieldCode="AU" term="%22Maby-El+Hajjami+H%22">Maby-El Hajjami H</searchLink>; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne, Switzerland; Department of Oncology, University Hospital Center (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cagnon+L%22">Cagnon L</searchLink>; Department of Oncology, University Hospital Center (CHUV) , Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Braun+M%22">Braun M</searchLink>; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland.<br /><searchLink fieldCode="AU" term="%22Derré+L%22">Derré L</searchLink>; Urology Research Unit, Urology Department, University Hospital Center (CHUV) , Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Rivals+JP%22">Rivals JP</searchLink>; Department of Otorhinolaryngology - Head and Neck Surgery, CHUV, University of Lausanne , Switzerland.<br /><searchLink fieldCode="AU" term="%22Rimoldi+D%22">Rimoldi D</searchLink>; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland.<br /><searchLink fieldCode="AU" term="%22Gnjatic+S%22">Gnjatic S</searchLink>; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , New York, USA.<br /><searchLink fieldCode="AU" term="%22Abed+Maillard+S%22">Abed Maillard S</searchLink>; Department of Oncology, University Hospital Center (CHUV) , Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Marcos+Mondéjar+P%22">Marcos Mondéjar P</searchLink>; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne, Switzerland; Department of Oncology, University Hospital Center (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Protti+MP%22">Protti MP</searchLink>; Tumor Immunology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Romano+E%22">Romano E</searchLink>; Department of Oncology, University Hospital Center (CHUV) , Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Michielin+O%22">Michielin O</searchLink>; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne, Switzerland; Department of Oncology, University Hospital Center (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Romero+P%22">Romero P</searchLink>; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne, Switzerland; Department of Oncology, University Hospital Center (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Speiser+DE%22">Speiser DE</searchLink>; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne, Switzerland; Department of Oncology, University Hospital Center (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jandus+C%22">Jandus C</searchLink>; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2016 Sep 09; Vol. 5 (10), pp. e1216290. <i>Date of Electronic Publication: </i>2016 Sep 09 (<i>Print Publication: </i>2016). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2162-4011 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27853637 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/2162402X.2016.1216290 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1216290 Titles: – TitleFull: Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Baumgaertner P – PersonEntity: Name: NameFull: Costa Nunes C – PersonEntity: Name: NameFull: Cachot A – PersonEntity: Name: NameFull: Maby-El Hajjami H – PersonEntity: Name: NameFull: Cagnon L – PersonEntity: Name: NameFull: Braun M – PersonEntity: Name: NameFull: Derré L – PersonEntity: Name: NameFull: Rivals JP – PersonEntity: Name: NameFull: Rimoldi D – PersonEntity: Name: NameFull: Gnjatic S – PersonEntity: Name: NameFull: Abed Maillard S – PersonEntity: Name: NameFull: Marcos Mondéjar P – PersonEntity: Name: NameFull: Protti MP – PersonEntity: Name: NameFull: Romano E – PersonEntity: Name: NameFull: Michielin O – PersonEntity: Name: NameFull: Romero P – PersonEntity: Name: NameFull: Speiser DE – PersonEntity: Name: NameFull: Jandus C IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 09 Text: 2016 Sep 09 Type: published Y: 2016 Identifiers: – Type: issn-print Value: 2162-4011 Numbering: – Type: volume Value: 5 – Type: issue Value: 10 Titles: – TitleFull: Oncoimmunology Type: main |
| ResultId | 1 |
